HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Vaccine coverage for 10-11 year-old children in Finistère, France in 2004: comparison with national average].

Abstract
Within the context of a cross-sectional survey to study the health status of 10 & 11-year-olds in Finistere (western France) in 2004, their vaccination status was also investigated. A random sample of 1003 children was selected, and 992 completed questionnaires were returned in response to the status of tuberculosis vaccination. 67% of children's cases corresponded to the acceptable vaccination status according to the French 1990 guidelines, including the BCG test. Prime injections were correctly carried out (ranging from 95% for measles to 97.7% for trivalent diphtheria, tetanus, and poliomyelitis [DTP] vaccines). Vaccine coverage rates were seen to decrease with the follow-up doses of injections required: 89% for the fourth dose of pertusis (whooping cough) vaccine and 91.9% for the fifth does of DTP. Coverage was remarkably lower for the third dose of hepatitis B vaccine and the second dose of trivalent measles, mumps, and rubella which have both been recommended later in France. The community and living environment (urban & rural) is a common factor found closely associated with vaccination compliance and coverage rates. For the most part, the vaccination rates for these children in Finistère were higher than the national ones.
AuthorsVéronique Thébaud, Claire Lietard, Diala Ktaiche
JournalSante publique (Vandoeuvre-les-Nancy, France) (Sante Publique) 2009 Jan-Feb Vol. 21 Issue 1 Pg. 55-64 ISSN: 0995-3914 [Print] France
Vernacular TitleCouverture vaccinate des enfants de CM2 (10-11 ans) du Finistère, France, en 2004 Comparaison avec les résultats nationaux.
PMID19425520 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Child
  • Cross-Sectional Studies
  • France
  • Humans
  • Vaccination (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: